Pulse Electromagnetic Field Therapy Devices Market Size, Share & Trends Analysis Report By Application (Bone Growth, Pain Relief), By Power (Low Frequency, High Frequency), By End-use, And Segment Forecasts, 2021 - 2028

Report Overview

The global pulse electromagnetic field therapy devices market size was valued at USD 359.5 million in 2020 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.8% over the forecast period. The increasing geriatric population across the globe and rising awareness regarding pulse electromagnetic field (PEMF) therapy devices are anticipated to boost the market growth. Technological advancements, such as the development of narrow, miniaturized PEMF therapy devices using advanced materials are expected to secure the market position. The integration of telemedicine is expected to expand the application scope of these devices. The novel coronavirus (COVID-19) disease has emerged disrupting various healthcare and socio-economical aspects across the globe.

Road accidents and trauma mostly result in severe spinal injuries as well as delayed union & nonunion fractures, which require surgical treatment. The PEMF therapy devices promote the healing of bones during treatment of failed spinal fusions, delayed unions, fracture nonunion, and fresh fractures. According to the International Osteoporosis Foundation, osteoporosis causes about 8.9 million fractures annually. In addition, around 1.6 million hip fractures take place globally each year, and this number is projected to reach between 4.5 and 6.3 million by 2050. Hence, increasing cases of osteoporosis are expected to drive the demand for PEMF therapy devices.

Pulse electromagnetic field (PEMF) therapy devices are safe and non-invasive with no significant side effects. PEMF therapy provides a novel alternative for the treatment of various musculoskeletal disorders. PEMF devices have been approved by the U.S. FDA to treat non-union fractures and cleared to treat post-operative osteoarthritis, plantar fasciitis, pain, and edema. These devices also have several benefits including reduction of chronic and acute pain related to several connective tissues, including bone, tendon, ligaments, cartilage injury as well as edema and inflammation control. Thus, the benefits of these devices are anticipated to accelerate market growth.

Lack of understanding of the mechanism of bone healing effect and poor experimental validation as achieved by PEMF therapy may limit market growth to some extent. The inadequate and inconclusive evidence along with the lack of support from the mainline clinical practice specialists has significantly limited the application scope of PEMF therapy devices. Although these devices are approved and regulated by the U.S. FDA, they need to be promoted and marketed as wellness products.

Power Insights

Based on power, the PEMF therapy devices market is segmented into low frequency and high frequency. The low-frequency power segment accounted for the largest revenue share of more than 62% in 2020. Low-frequency PEMF devices apply magnetic fields with typically medium-high intensities but at low frequencies. Also, these devices are intended for the treatment of delayed bone union and hard tissues. Furthermore, low-frequency PEMF devices can provide safe, non-invasive, and easy-to-apply techniques to treat inflammation, pain, and dysfunctions associated with osteoarthritis and rheumatoid arthritis. Thus, increasing usage of low-frequency PEMF therapy devices in the treatment of arthritis is expected to propel segment growth.

The high-frequency power segment is expected to grow at the fastest CAGR during the forecast period. High-frequency PEMF devices are suited for the treatment of conditions affecting soft tissues including muscles and tendons. Researchers have found that these devices improved edema up to some hours after the treatment session. In addition, people with neck pain as a sign of acute stroke had momentous improvement in pain as compared to controls when treated with high-frequency PEMF therapy devices. All these factors are projected to have a positive impact on the segment growth.

Application Insights

The pain relief application segment accounted for the highest revenue share of more than 44% in 2020. PEMF therapy devices provide an optimal magnetic field that reduces pain by enhancing the expansion and contraction of cells and also by detoxifying and regenerating damaged cells. The incidence of chronic pain is rising all across the globe. For instance, according to the CDC, in 2019, nearly 20.4% of adults had chronic pain and about 7.4% of adults were suffering from chronic pain. In addition, from the same source, high-impact chronic pain, as well as chronic pain, increased with age and was highest among adults aged 65 years and above in 2019. Hence, rising cases of chronic pain among adults are anticipated to fuel the segment growth.

The bone growth segment is estimated to register a significant CAGR from 2021 to 2028. Pulsed electromagnetic fields are known to act on bone and osteoblasts, affecting its metabolism, despite the poor understanding of underlying mechanisms. The growth of PEMF therapy and its development over the ages for usage in post-operative bone growth has been innovative in its effect on vascular flow and bone tissue proliferation. Moreover, numerous clinical trials have discovered that PEMF therapy devices are capable of promoting osteogenesis and considerably increasing bone mineral density. Thus, the aforementioned factors are expected to boost the segment growth.

End-use Insights

The hospitals segment led the market in 2020 and accounted for more than 50% of the global revenue share. Hospitals are majorly the first choice of patients to visit for chronic pain and several bone disorders including osteoporosis and osteoarthritis, among others. Increasing hospital admissions of patients suffering from spinal injuries, traumatic injuries, fractures, and road accidents are expected to accelerate the segment growth.

The home care settings segment is expected to grow at a significant CAGR from 2021 to 2028. The growth can be attributed to the rising healthcare awareness among individuals and product advancements. PEMF therapy devices can be easily handled by patients at home for management of chronic & acute pain, fractures, osteoporosis, and arthritis, thereby securing the market demand.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 41.2% in 2020. An increasing number of patients suffering from osteoporosis and osteoarthritis is predicted to boost the demand for PEMF therapy devices in the U.S. and Canada. In addition, the ongoing transition towards minimally invasive procedures is predicted to enhance regional growth. Also, the presence of a well-developed healthcare structure in the U.S. is anticipated to boost the product demand.

In Asia Pacific, the market is estimated to witness the fastest CAGR during the forecast period. Rising patient awareness levels related to the commercial availability of PEMF therapy devices and constantly improving healthcare infrastructure are anticipated to accelerate the market growth. The rising popularity of home healthcare and the increasing geriatric population in several developing economies of Asia Pacific is also expected to boost the regional market growth.

Key Companies & Market Share Insights

Regulatory product approvals, mergers & acquisitions, strategic collaborations, and product launches are some of the important strategies used by market players to maintain and expand their global reach. For instance, in October 2018, NewMed, a subsidiary of Bedfont Scientific Limited, teamed up with experts to launch its new division and offer PEMF devices for healthcare specialists. The company’s several devices offer PEMF therapy at higher intensities for stimulating cellular repair to improve an individual’s overall body performance. The following are some of the major players operating in the global pulse electromagnetic field therapy devices market:

• Bedfont Scientific

• Orthofix Holdings

• I-Tech Medical Division

• OSKA

• Medithera

• NiuDeSai

• Nuage Health

• Oxford Medical Instruments Health

• Bemer, LLC

Pulse Electromagnetic FieldTherapy Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global pulse electromagnetic field therapy devices market report on the basis of power, application, end-use, and region:

• Power Outlook (Revenue in USD Million, 2016 - 2028)

  • Low Frequency

  • High Frequency

• Application Outlook (Revenue in USD Million, 2016 - 2028)

  • Pain Management

  • Bone Growth

  • Others

• End-use Outlook (Revenue in USD Million, 2016 - 2028)

  • Hospitals

  • Home Care Settings

  • Others

• Regional Outlook (Revenue in USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Thailand

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE